You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bictegravir/Emtricitabine/Tenofovir alafenamide

Showing 1 - 25 of 825
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Barcelona (Biktarvy 50 mg/200 mg/25 mg film-coated tablets)

Not yet recruiting
  • HIV Infections
  • Biktarvy 50 mg/200 mg/25 mg film-coated tablets
  • Barcelona, Spain
    Hospital Clinic i Provincial Barcelona
Oct 26, 2022

HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

Not yet recruiting
  • HIV
  • HIV Infections
  • (no location specified)
Aug 4, 2023

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Dec 19, 2022

HIV-1-infection Trial in San Francisco (Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch)

Completed
  • HIV-1-infection
  • Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch
  • San Francisco, California
    SFOMG Private Practice
Jan 27, 2022

Health-related Quality of Life in HIV-1 Infected Adults

Active, not recruiting
  • HIV-1-infection
  • Montréal, Canada
  • +5 more
Sep 22, 2022

HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)

Recruiting
  • HIV Infections
  • Renal Transplant Rejection
  • BIKTARVY 50Mg-200Mg-25Mg Tablet
  • New York, New York
    Weill Cornell Medicine
Aug 1, 2022

HIV, Obesity Trial in Greenville (Biktarvy, Symtuza)

Not yet recruiting
  • HIV Infections
  • Obesity
  • Greenville, North Carolina
    Adult Specialty Care Clinic-East Carolina University
Jul 14, 2022

Health-related Quality of Life in HIV-1 Infected Adults

Active, not recruiting
  • HIV-1-infection
  • B/F/TAF
  • Haifa, Israel
  • +4 more
Mar 8, 2022

Hiv, Transgenderism Trial in Toronto (Biktarvy 50/200/25 Tab, Estradiol Tablets)

Recruiting
  • Hiv
  • Transgenderism
  • Biktarvy 50/200/25 Tab
  • Estradiol Tablets
  • Toronto, Ontario, Canada
    Maple Leaf Research
Dec 15, 2022

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

HIV Trial (DTG/3TC)

Not yet recruiting
  • HIV
  • (no location specified)
Jun 9, 2023

HIV Prevention Trial in Boston (bictegravir)

Completed
  • HIV Prevention
  • Boston, Massachusetts
    Fenway Community Health
Apr 6, 2022

HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

Terminated
Has Results
  • HIV-1-infection
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 21, 2022

HIV Trial in Madrid (Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY])

Not yet recruiting
  • HIV Infections
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Madrid, Spain
    H. Infanta Leonor
Jun 2, 2022

HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

Active, not recruiting
  • HIV I Infection
  • Dolutegravir / Lamivudine Pill
  • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
  • Orlando, Florida
    Orlando Immunology Center
Sep 20, 2022

HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

Terminated
  • HIV-1-infection
  • Biktarvy Tab
  • Saint Louis, Missouri
    Southampton Healthcare, Inc.
Jan 3, 2023

HIV Trial in Boston (Biktarvy)

Active, not recruiting
  • HIV
  • Boston, Massachusetts
  • +2 more
Jun 7, 2021

HIV Trial in Houston (B/FTC/TAF, Current ART)

Terminated
Has Results
  • HIV Infections
  • Houston, Texas
    Thomas Street Health Center
Sep 1, 2022

HIV-1-infection Trial in Clamart, Le Kremlin-Bicêtre, Paris (Biopsies and bloood samplings)

Not yet recruiting
  • HIV-1-infection
  • Biopsies and bloood samplings
  • Clamart, France
  • +5 more
Jan 24, 2022

Healthy Trial (JNJ-56136379, Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF))

Withdrawn
  • Healthy
  • JNJ-56136379
  • Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
  • (no location specified)
Jul 12, 2021

HIV Trial in Toronto (drug, behavioral, other)

Recruiting
  • HIV Infections
  • Toronto, Ontario, Canada
  • +2 more
Nov 19, 2021

HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)

Active, not recruiting
  • HIV-1/HBV Co-Infection
  • Fort Pierce, Florida
  • +66 more
Sep 19, 2022

Severity of Drug Interactions Before and After Switching

Completed
  • HIV/AIDS
  • bictegravir/emtricitabine/tenofovir alafenamide
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 5, 2020

HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

Recruiting
  • HIV/AIDS
  • Tuberculosis, Pulmonary
  • Biktarvy®
  • TLD- fixed-drug combination single tablet
  • Durban, KwaZulu-Natal, South Africa
    CAPRISA Springfield Clinical Research Site
Mar 14, 2022